MedPath

TRF Pharma, Inc.

🇺🇸United States
Ownership
Private
Employees
-
Market Cap
-
Website

TRF-1101 Assessment in Sickle Cell Disease

Phase 1
Terminated
Conditions
Sickle Cell Disease
Interventions
Drug: Placebo
First Posted Date
2008-10-16
Last Posted Date
2009-05-11
Lead Sponsor
TRF Pharma, Inc
Target Recruit Count
80
Registration Number
NCT00773890
Locations
🇺🇸

Boston Medical Center, Boston, Massachusetts, United States

🇺🇸

University of North Carolina, Chapel Hill, North Carolina, United States

🇺🇸

Medical College of Georgia, Augusta, Georgia, United States

and more 3 locations
© Copyright 2025. All Rights Reserved by MedPath